Rezdiffra (resmetirom) - Madrigal Pharma
Rezdiffra: Launch in EU for MASH in H2 2025 (43rd Annual J.P. Morgan Healthcare Conference, Madrigal Pharmaceuticals) Jan 24, 2025 
Launch Europe Metabolic Dysfunction-Associated Steatohepatitis
https://ir.madrigalpharma.com/static-files/ecff0bde-5305-42e8-bdcc-9bf8d8bfbc5f
 
Jan 24, 2025
 
 
dbf7c2c2-09a7-4866-86c9-4f36c2f3d4e1.png